Wanyong Chen
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Targeting ALK averts ribonuclease 1-induced immunosuppression and enhances antitumor immunity in hepatocellular carcinoma.
Journal: Nature communications
Published: October 20, 2023
The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients.
Journal: International journal of general medicine
Published: November 25, 2021
Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients.
Journal: Annals of translational medicine
Published: April 12, 2021
Quiescin sulfhydryl oxidase 1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by driving EGFR endosomal trafficking and inhibiting NRF2 activation.
Journal: Redox biology
Published: January 14, 2021
Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: January 06, 2021
High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patients.
Journal: American journal of cancer research
Published: July 27, 2020
High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection.
Journal: Annals of translational medicine
Published: May 13, 2020
A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma.
Journal: Frontiers in oncology
Published: August 02, 2019
A robust 6-mRNA signature for prognosis prediction of pancreatic ductal adenocarcinoma.
Journal: International journal of biological sciences
Published: July 07, 2019
Last Updated: 09/26/2026